Responsive Table
| VMFN Partner | WHO LMIC Region | Modality Status at each VMFN Partner | ||
| mRNA | rProtein | Viral Vector | ||
| Aspen (drug product f/f only) | Africa | |||
| IPD | ||||
| Serum Institute of India | SE Asia | |||
| BioFarma | ||||
| Fiocruz-BioManguinhos | LAC | |||
| Samsung Biologics | W Pacific | |||
Key
| Developed | Developing | To be developed |